BR112022015952A2 - Composições de peptídeos e métodos de uso das mesmas - Google Patents

Composições de peptídeos e métodos de uso das mesmas

Info

Publication number
BR112022015952A2
BR112022015952A2 BR112022015952A BR112022015952A BR112022015952A2 BR 112022015952 A2 BR112022015952 A2 BR 112022015952A2 BR 112022015952 A BR112022015952 A BR 112022015952A BR 112022015952 A BR112022015952 A BR 112022015952A BR 112022015952 A2 BR112022015952 A2 BR 112022015952A2
Authority
BR
Brazil
Prior art keywords
methods
peptide compositions
peptides
compositions
peptide
Prior art date
Application number
BR112022015952A
Other languages
English (en)
Inventor
Charles Wimley William
Gannon Starr Charles
Guha Shantanu
Ghimire Jenisha
Original Assignee
The Administrators Of The Tulane Educational Fund
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Administrators Of The Tulane Educational Fund filed Critical The Administrators Of The Tulane Educational Fund
Publication of BR112022015952A2 publication Critical patent/BR112022015952A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/50—Isolated enzymes; Isolated proteins
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P1/00—Disinfectants; Antimicrobial compounds or mixtures thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

COMPOSIÇÕES DE PEPTÍDEOS E MÉTODOS DE USO DAS MESMAS. A presente invenção refere-se a peptídeos antimicrobianos, polinucleotídeos que codificam os peptídeos, e composições contendo os peptídeos. Além disso, são descritos no presente documento métodos para usar os peptídeos, polinucleotídeos e composições para pesquisa e terapia.
BR112022015952A 2020-02-14 2021-02-12 Composições de peptídeos e métodos de uso das mesmas BR112022015952A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202062976694P 2020-02-14 2020-02-14
PCT/US2021/018031 WO2021163620A1 (en) 2020-02-14 2021-02-12 Peptide compositions and methods of use thereof

Publications (1)

Publication Number Publication Date
BR112022015952A2 true BR112022015952A2 (pt) 2022-11-22

Family

ID=77292744

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022015952A BR112022015952A2 (pt) 2020-02-14 2021-02-12 Composições de peptídeos e métodos de uso das mesmas

Country Status (8)

Country Link
US (1) US20230310540A1 (pt)
EP (1) EP4087595A4 (pt)
CN (1) CN115209912A (pt)
AU (1) AU2021218442A1 (pt)
BR (1) BR112022015952A2 (pt)
CA (1) CA3167422A1 (pt)
MX (1) MX2022009965A (pt)
WO (1) WO2021163620A1 (pt)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2046825A1 (en) * 2006-07-11 2009-04-15 Austria Wirtschaftsservice Gesellschaft mbH Antimicrobial peptide derived from galanin message associated peptide (gmap)
US7521535B2 (en) * 2006-09-20 2009-04-21 The Board Of Regents For Oklahoma State University Anti-microbial defensin-related peptides and methods of use
WO2016132359A2 (en) * 2015-02-22 2016-08-25 Omnix Medical Ltd. Antimicrobial peptides
EP3323827A1 (en) * 2016-11-21 2018-05-23 Christian-Albrechts-Universität zu Kiel Cationic intrinsically disordered antimicrobial peptides
US11266743B2 (en) * 2017-10-25 2022-03-08 The Administrators Of The Tulane Educational Fund Peptide compositions and methods of use thereof

Also Published As

Publication number Publication date
EP4087595A4 (en) 2024-02-28
CN115209912A (zh) 2022-10-18
US20230310540A1 (en) 2023-10-05
EP4087595A1 (en) 2022-11-16
MX2022009965A (es) 2022-11-09
CA3167422A1 (en) 2021-08-19
AU2021218442A1 (en) 2022-09-01
WO2021163620A1 (en) 2021-08-19

Similar Documents

Publication Publication Date Title
CL2019002134A1 (es) Composiciones terapéuticas inmunomoduladoras de arnm que codifican péptidos de activación de mutaciones oncogénicas.
CL2021001744A1 (es) Péptidos y combinaciones de péptidos para el uso en la inmunoterapia contra el cáncer de próstata y otros tipos de cáncer (divisional de la solicitud no. 201800324)
EA201990071A1 (ru) Композиция пептидной вакцины
BR112019018307A2 (pt) Plataforma para identificação de peptídeos imunogênicos baseada em população
BRPI0607326B8 (pt) composição de vacina, uso da referida composição e kit em partes
CL2019002368A1 (es) Composiciones y métodos para el tratamiento de cáncer.
BR112019012796A2 (pt) proteínas de ligação ao antígeno antineuropilina e métodos de uso das mesmas
UA117096C2 (uk) Поліпептид, що зв'язується з c5 комплементу людини
BR112019023337A2 (pt) Ligase engenheirada, sequência de polinucleotídeo, vetor de expressão, célula hospedeira, métodos para produzir um polipeptídeo da ligase engenheirada, um produto de ligação, uma biblioteca de dna e uma pluralidade de fragmentos de dna adequados para sequenciamento, e, composição
CO2019002523A2 (es) Inhibidores de dopamina–β–hidroxilasa penetrantes de la barrera hematoencefálica
EA202190888A1 (ru) Пептид для применения в косметике
CO2021007916A2 (es) Ácido ribonucleico (arn) que codifica para una proteína
BR112022017192A2 (pt) Variantes de transglutaminase
BR112022023723A2 (pt) Polipeptídeo, composição, polinucleotídeo, vetor, célula hospedeira, métodos para prevenção e/ou tratamento de uma doença relacionada à excitotoxicidade e/ou dor neuropática e para fabricar o polipeptídeo, uso do polipeptídeo, da composição, do polinucleotídeo, do vetor ou da célula hospedeira, e, kit de peças
AR081866A1 (es) Variantes de peptidos antimicrobianos y polinucleotidos que las codifican
PH12019501064A1 (en) Ras PROTIEIN DEGRADATION INDUCING MOLECULE AND PHARMACEUTICAL COMPOSITION
BR112022007203A2 (pt) Compostos imunogênicos para tratamento de câncer adrenal
UY39464A (es) Composiciones y métodos para la prevención y/o tratamiento de la covid-19
BR112023017749A2 (pt) Composições incluindo adjuvantes sbi e métodos de uso das mesmas
BR112022015952A2 (pt) Composições de peptídeos e métodos de uso das mesmas
BR112022017032A2 (pt) Composições compreendendo ltb e antígenos patogênicos, e uso das mesmas.
BR112021013206A2 (pt) Bibliotecas de peptídeos e respectivos métodos de uso
PE20190967A1 (es) Aislados modificados de streptomyces fungicidicus y su uso
EA202190096A1 (ru) Композиция, содержащая аналог соматостатина, для радиофармацевтического применения
BR112018011590A2 (pt) formulação cosmética